NEW YORK (360Dx) – Laboratory Corporation of America announced today that it will acquire specialty contract research organization Chiltern for roughly $1.2 billion in cash.

According to LabCorp, Chiltern brings a strong presence among emerging-to-mid biopharma customers, as well as expertise in early-stage drug development, medical device development, and oncology. It also offers robust functional service provider (FSP) solutions and an endpoint suite of interactive response technology.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.